Search Results
160 items found for "Targeted therapy"
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
), a G protein-coupled receptor (GPCR) expressed predominantly on eosinophils, is an important drug target
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
associated with apoptosis and cell cycle arrest, making these receptor subtypes better differentiated targets
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
Several of these targets are being developed for potential new therapeutic strategies in ovarian and
- Distinct sub-cellular signal propagation as a component of functional selectivity
signaling and GPCRs and made seminal contributions to our understanding of this major class of drug targets
- The landscape of cancer-rewired GPCR signaling axes
., muscarinic, adenosine, 5-hydroxytryptamine, and chemokine receptors, are the targets of multiple drugs
- [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines
Cancer Cell Lines Published date September 7, 2023 Abstract "A3 adenosine receptor is an interesting target
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
Mechanistic studies revealed that 8GL treatment inhibits the activation of the mammalian target of rapamycin
- Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis
cell-specific Adra2a knockout mice, we show that Enterococcus-derived tyramine suppresses ISC proliferation, thereby revealing a causal link between microbial regulation of ISCs and colitis exacerbation and yielding a targeted
- GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma
glioblastoma (GBM) and is involved in the mesenchymal transition, making it a promising therapeutic target
- Trainee Symposium I
GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain
- GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Therapeutic targeting CCR1 showed promising efficacy with EBV eradication, T-cell activation, and lymphoma
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
BLT2 mediates macrophage migration during inflammation, which implicates it as a potential therapeutic target
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
Although G protein-coupled receptors (GPCRs) are among the targets of current antifibrotic drugs, no
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
One approach to treating patients suffering from lung cancer is to target surface receptors overexpressed
- Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report
Due to the urgency of finding therapies for post-COVID-Syndrome (PCS), we report here the interim results controlled trial (RCT), including sham apheresis, and for an RCT combining IA with B-cell depletion therapy
- CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation
Mechanistically, circFKBP5 acted as a sponge for miR-708-5p, which was verified to target GIT2.
- TIPE proteins control directed migration of human T cells by directing GPCR and lipid second messenger signaling
These findings have implications for therapeutically targeting TIPE proteins in human inflammatory and
- RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment
VSMCs in vivo by adeno-associated virus type 9 (AAV) carrying RGS5 cDNA or small hairpin RNA (shRNA) targeting
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
chronic kidney disease (CKD) and G-protein coupled receptors (GPCRs) are the most druggable therapeutic targets
- Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
inflammasome, Nrf2-ARE anti-oxidant, or heat-shock activation pathway) that triggers expression of a suite of target
- A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages
understanding of metabolite-sensing GPCRs, such as GPR109A, could establish their potential as therapeutic targets
- Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4
reveal a new GPR81-driven mechanism in breast cancer and substantiate GPR81 as a promising treatment target
- Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Mthl10
Moreover, the GBP2-induced response was silenced by pre-treatment with dsRNA targeting the GBP receptor
- Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways
chemotherapy, and could potentially serve as a tool to predict combinatorial efficacy and assist in target
- Ep 36 with Dr. Michel Bouvier
signaling and GPCRs and made seminal contributions to our understanding of this major class of drug targets
- Classified News | Dr. GPCR Ecosystem
October 1, 2022 GPCRs: Signal Transduction Read More GPCR Binders, Drugs, and More October 1, 2024 Target-based
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
activates PI3K/Akt/mTOR signal transduction pathways to mediate epithelial-mesenchymal transition (EMT), thereby Therefore, our findings demonstrated that GPR37 may represent a viable therapeutic target for NSCLC."
- Ep 82 with Dr. Lauren M. Slosky
neuropeptide G protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted